205 related articles for article (PubMed ID: 29266077)
1. ACOG Committee Opinion No. 727: Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer.
Committee on Gynecologic Practice
Obstet Gynecol; 2018 Jan; 131(1):e31-e34. PubMed ID: 29266077
[TBL] [Abstract][Full Text] [Related]
2. ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer.
Obstet Gynecol; 2018 Jan; 131(1):194-195. PubMed ID: 29266071
[TBL] [Abstract][Full Text] [Related]
3. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
[TBL] [Abstract][Full Text] [Related]
4. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
Obstet Gynecol; 2019 Dec; 134(6):e143-e149. PubMed ID: 31764758
[TBL] [Abstract][Full Text] [Related]
5. Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results.
Obstet Gynecol; 2017 Apr; 129(4):771-772. PubMed ID: 28333813
[TBL] [Abstract][Full Text] [Related]
6. Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.
Obstet Gynecol; 2017 Apr; 129(4):e96-e101. PubMed ID: 28333821
[TBL] [Abstract][Full Text] [Related]
7. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
Lewis KM
Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
9. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
[TBL] [Abstract][Full Text] [Related]
10. Committee Opinion No. 639: The Importance of Vital Records and Statistics for the Obstetrician-Gynecologist.
Obstet Gynecol; 2015 Sep; 126(3):e28-e30. PubMed ID: 26287790
[TBL] [Abstract][Full Text] [Related]
11. Committee Opinion Summary No. 639: The Importance of Vital Records and Statistics for the Obstetrician-Gynecologist.
Obstet Gynecol; 2015 Sep; 126(3):690. PubMed ID: 26287783
[TBL] [Abstract][Full Text] [Related]
12. Legal Considerations in Genetic Screening and Testing: Three Case Studies: ACOG Committee Opinion Summary, Number 805.
Obstet Gynecol; 2020 Apr; 135(4):994-995. PubMed ID: 32217975
[TBL] [Abstract][Full Text] [Related]
13. Legal Considerations in Genetic Screening and Testing: Three Case Studies: ACOG Committee Opinion, Number 805.
Obstet Gynecol; 2020 Apr; 135(4):e189-e192. PubMed ID: 32217981
[TBL] [Abstract][Full Text] [Related]
14. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
15. ACOG Committee Opinion No. 729: Importance of Social Determinants of Health and Cultural Awareness in the Delivery of Reproductive Health Care.
Committee on Health Care for Underserved Women
Obstet Gynecol; 2018 Jan; 131(1):e43-e48. PubMed ID: 29266079
[TBL] [Abstract][Full Text] [Related]
16. Strategies for clinical implementation of screening for hereditary cancer syndromes.
Heald B; Marquard J; Funchain P
Semin Oncol; 2016 Oct; 43(5):609-614. PubMed ID: 27899194
[TBL] [Abstract][Full Text] [Related]
17. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
Raymond VM; Everett JN
Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
[TBL] [Abstract][Full Text] [Related]
18. Multigene Testing for Hereditary Cancer: When, Why, and How.
Offit K
J Natl Compr Canc Netw; 2017 May; 15(5S):741-743. PubMed ID: 28515260
[TBL] [Abstract][Full Text] [Related]
19. Committee opinion no. 634: Hereditary cancer syndromes and risk assessment.
Obstet Gynecol; 2015 Jun; 125(6):1538-1543. PubMed ID: 26000542
[TBL] [Abstract][Full Text] [Related]
20. Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.
Caeser R; Chiang J; Tan ES; Tai ES; Ngeow J
Fam Cancer; 2024 Jun; 23(2):133-140. PubMed ID: 38662262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
